# Hyperleukocytosis, leukemoid reaction caused by malignant peritoneal mesothelioma: a case report and review of literature

**Authors:** Kaibo Zhu, Dan Zhou, Kang Liu, Lingzhen Wu, Juan Jin, Zimian Luo

PMC · DOI: 10.3389/fonc.2025.1550868 · Frontiers in Oncology · 2025-05-14

## TL;DR

A rare case of a non-hematological cancer causing high white blood cell count highlights the need for broader diagnostic considerations.

## Contribution

The case introduces a novel association between malignant peritoneal mesothelioma and paraneoplastic leukemoid reaction.

## Key findings

- Malignant peritoneal mesothelioma can present with hyperleukocytosis mimicking hematological malignancies.
- Glucocorticoids may be a potential treatment for paraneoplastic leukemoid reactions.
- Early recognition of PLR is crucial to avoid misdiagnosis as leukemia or myeloproliferative neoplasms.

## Abstract

Paraneoplastic leukemoid reaction (PLR)-induced hyperleukocytosis remains a critical diagnostic challenge. Malignant peritoneal mesothelioma, known for its nonspecific clinical presentation, often evades early detection. We report a 75-year-old male with cirrhosis presenting with fever (38.2°C), progressive ascites, leukocytosis (109.9×109/L), and elevated CRP (247.41 mg/L). Initial diagnosis of spontaneous peritonitis failed to explain the leukocytosis, prompting bone marrow examination, including cytomorphology and genetic analysis, which turned out do not support a diagnosis of leukemia or myeloproliferative neoplasms. Subsequent peritoneal biopsy confirmed diffuse malignant peritoneal mesothelioma. Despite prompt diagnosis, the patient developed progressive multi-organ dysfunction and died on day 14. This case underscores the imperative to consider PLR as a potential cause of hyperleukocytosis in oncological contexts, rather than attributing it solely to hematological malignancies. Moreover, it highlights the importance of considering malignant peritoneal mesothelioma in the differential diagnosis of unexplained ascites and peritoneal thickening. Additionally, we propose the hypothesis that glucocorticoids may hold therapeutic potential in the management of PLR.

## Linked entities

- **Diseases:** cirrhosis (MONDO:0005155), malignant peritoneal mesothelioma (MONDO:0005512)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** fever (MESH:D005334), leukemia (MESH:D007938), PLR (MESH:D007955), myeloproliferative neoplasms (MESH:D009369), peritonitis (MESH:D010538), multi-organ dysfunction (MESH:D009102), leukocytosis (MESH:D007964), ascites (MESH:D001201), hematological malignancies (MESH:D019337), Malignant peritoneal mesothelioma (MESH:D000086002), cirrhosis (MESH:D005355)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12116308/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12116308/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12116308/full.md

---
Source: https://tomesphere.com/paper/PMC12116308